Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
167
NCT04882631
A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 12, 2021
Completion: May 3, 2021
NCT04901806
Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors
Start: Jul 20, 2021
Completion: Jul 26, 2023
NCT05160389
A Study to Assess the Effect of Food on the Absorption and Bioavailability of PBI-200
Start: Nov 17, 2021
Completion: Jan 6, 2022
NCT05514353
A Phase 1 Study to Assess Single and Multiple Ascending Doses of PBI-100 Topical Cream
Start: Dec 28, 2021
Completion: Jan 12, 2023
NCT05238337
A Phase 1 Study of the Absorption, Metabolism, and Excretion of [14C] PBI-200
Start: Feb 24, 2022
Completion: Mar 24, 2022
NCT05690932
A Formulation Bridging and Food Effect Study of PBI-200 in Healthy Volunteers
Completion: May 23, 2022
NCT05692570
A Study of PBI-200 With Ritonavir or Cobicistat in Healthy Volunteers
Start: Sep 9, 2022
Completion: Nov 12, 2022